Phase II study of everolimus with biomarker exploration in patients with
advanced gastric cancer refractory to chemotherapy including fluoropyrimidine
and platinum
Phase II study of everolimus with biomarker exploration in patients with
advanced gastric cancer refractory to chemotherapy including fluoropyrimidine
and platinum
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search